• Japanese
  • Korean
  • Chinese
Cover Image

Injectable Drug Delivery to 2020

Abstract

Greystone Research Associates is pleased to announce the publication of a new market study. Injectable Drug Delivery to 2016: Drugs, Devices, Therapies, Markets and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for injectable drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Product Integration and Injectable Drug Delivery

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.

image1

Table of Contents

Executive Summary

Injectable Drug Delivery Market Dynamics

  • The Injectable Drug Ecosystem
  • Competitive Landscape
  • Injectable Drug Demand Drivers
  • Risks and Opportunities

Injectable Drug Device Selection Criteria

  • Stability and Material Selection Issues
  • Single vs Multi-Dose Devices
  • Lyophilized Drugs/Reconstitution
  • Syringe Safety/Sharps Protection
  • Needle Configuration Strategies
  • Disposable Drug Cartridges
  • Human Engineering/Ergonomics
  • Branding/Private Labeling

Injectable Drug Delivery - Device Segments

  • Autoinjectors
  • Needle-free Injectors
  • Pen Injectors
  • Prefilled Syringes
  • Safety Syringes

Injectable Drug Delivery - Therapeutic Segment Analysis & Forecasts

  • Anaphylaxis
  • Anticoagulants
  • Antivirals
  • Autoimmune Diseases
  • Emergency Medicine
  • Hematopoietics
  • Hormone Replacement
  • Metabolic Diseases
  • Neurology
  • Reproductive Health
  • Vaccines

Injectable Drug Therapeutics - Market Factors

  • Regulatory Factors and Issues
  • Sharps Legislations
  • Clinical Trial Factors
  • Managed Care and Healthcare Economics

Company Profiles

Note: The Table of Contents has Been Edited for Brevity. For a Completed Version, Please Request a Free Sample.

Show More
Pricing
Get Notified
Email me when related reports are published